This example shows a collection of vital signs for subject ABC-001-001, where the time was not collected. The dosing regimen is once-weekly administration, which is why the first dose of the study (VSTPTREF) is on study day 1 (VSDY) and the second dose is on study day 8.
Rows 1-8:
VSELTM show planned elapsed times after the first dose and after the second dose for a series of vital signs measurements.
Rows 4, 8:
The study plan stated that the last measurement should be performed 4 to 6 hours post dosing (shown in VSTPT). The applicant chose to show this as a planned elapsed time of 4 hours in VSELTM.